This was the stock's second consecutive day of losses.

Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

UnitedHealth Group Incorporated UNH has plunged 26.9% since reporting disappointing first-quarter 2025 results and slashing ...

Although the economy's health is now tied to many other sectors, the DJIA is still seen as a vital indicator of the U.S. economy's well-being. Although the Dow Jones Industrial Average rarely ...

There are plenty of compelling opportunities in the sector due to innovative medications and treatments being developed through genomics research.

a rise with lots of oscillations on Wednesday—that a record set by the Dow Jones Industrial Average on last week’s final day of trading has been largely overlooked. That’s unfortunate ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Elevance Health (ELV – Research Report). The ...

According to data from MarketBeat.com, Elevance Health presently has an average rating of “Moderate Buy” and a consensus price target of $509.44. ELV stock opened at $421.55 on Wednesday.

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

SPDR Dow Jones Global Real Estate ETF Stock Down 0.3 % SPDR Dow Jones Global Real Estate ETF stock opened at $42.94 on Friday. The business has a 50-day simple moving average of $43.09 and a two ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Wall Street trading got off to a mixed start on Tuesday after Donald Trump made yet another tariff concession, this time ...